Detalhe da pesquisa
1.
Inter-relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management.
Diabetes Obes Metab
; 26(5): 1567-1581, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328853
2.
First-in-human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations.
Diabetes Obes Metab
; 25(9): 2447-2456, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380614
3.
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Diabetes Obes Metab
; 25(1): 46-55, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111434
4.
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Am Heart J
; 243: 232-239, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34666013
5.
Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study.
Diabetes Obes Metab
; 24(9): 1734-1740, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35546275
6.
Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER.
BMC Endocr Disord
; 22(1): 111, 2022 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35473607
7.
Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT.
Diabetologia
; 64(1): 56-69, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33146763
8.
Incidence of sight-threatening diabetic retinopathy in an established urban screening programme: An 11-year cohort study.
Diabet Med
; 38(9): e14583, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830513
9.
Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR-TIMI 53 cardiovascular outcomes trials.
Diabetes Obes Metab
; 23(5): 1101-1110, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33394543
10.
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study.
Diabetes Obes Metab
; 23(10): 2336-2343, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34212481
11.
Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk.
Cardiovasc Diabetol
; 19(1): 196, 2020 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222693
12.
Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus.
Am J Nephrol
; 51(1): 74-82, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31812955
13.
Cardiovascular protection with sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Does it apply to all patients?
Diabetes Obes Metab
; 22(9): 1481-1495, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285611
14.
Personalized risk-based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules.
Diabetes Obes Metab
; 21(3): 560-568, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30284381
15.
Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes.
Diabetes Obes Metab
; 20(3): 541-548, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28862801
16.
Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data.
Diabetes Obes Metab
; 19(3): 329-335, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27862902
17.
Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study.
BMC Endocr Disord
; 14: 61, 2014 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25048824
18.
Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study.
Diabetes Res Clin Pract
; 185: 109218, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35114299
19.
Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER study.
Indian Heart J
; 74(5): 398-405, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35926587
20.
Type 2 diabetes and heart failure: insights from the global DISCOVER study.
ESC Heart Fail
; 8(2): 1711-1716, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33570253